0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pet Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-38S5696
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Pet Drug Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Pet Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-38S5696
Report
October 2024
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pet Drug - Market Size

The global market for Pet Drug was estimated to be worth US$ 12930 million in 2023 and is forecast to a readjusted size of US$ 20540 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030

Pet Drug - Market

Pet Drug - Market

In this report, we study the Veterinary Products for Pet mainly medicines
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 458%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pet Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pet Drug by region & country, by Type, and by Application.
The Pet Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Drug.
Market Segmentation

Scope of Pet Drug - Market Report

Report Metric Details
Report Name Pet Drug - Market
Forecasted market size in 2030 US$ 20540 million
CAGR 6.8%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Dogs
  • Cats
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Parnell
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Pet Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Pet Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Pet Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Pet Drug - Market size in 2030?

Ans: The Pet Drug - Market size in 2030 will be US$ 20540 million.

What is the Pet Drug - Market share by region?

Ans: According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Pet Drug - Market report?

Ans: The main players in the Pet Drug - Market are Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Parnell

What are the Application segmentation covered in the Pet Drug - Market report?

Ans: The Applications covered in the Pet Drug - Market report are Dogs, Cats, Other

What are the Type segmentation covered in the Pet Drug - Market report?

Ans: The Types covered in the Pet Drug - Market report are Antiparasitic Drugs, Antibacterial, Other

Recommended Reports

Pet Pharmaceuticals

Pet Nutrition

Pet Healthcare

1 Market Overview
1.1 Pet Drug Product Introduction
1.2 Global Pet Drug Market Size Forecast
1.3 Pet Drug Market Trends & Drivers
1.3.1 Pet Drug Industry Trends
1.3.2 Pet Drug Market Drivers & Opportunity
1.3.3 Pet Drug Market Challenges
1.3.4 Pet Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pet Drug Players Revenue Ranking (2023)
2.2 Global Pet Drug Revenue by Company (2019-2024)
2.3 Key Companies Pet Drug Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pet Drug Product Offered
2.5 Key Companies Time to Begin Mass Production of Pet Drug
2.6 Pet Drug Market Competitive Analysis
2.6.1 Pet Drug Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pet Drug Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Drug as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antiparasitic Drugs
3.1.2 Antibacterial
3.1.3 Other
3.2 Global Pet Drug Sales Value by Type
3.2.1 Global Pet Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pet Drug Sales Value, by Type (2019-2030)
3.2.3 Global Pet Drug Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Dogs
4.1.2 Cats
4.1.3 Other
4.2 Global Pet Drug Sales Value by Application
4.2.1 Global Pet Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pet Drug Sales Value, by Application (2019-2030)
4.2.3 Global Pet Drug Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pet Drug Sales Value by Region
5.1.1 Global Pet Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pet Drug Sales Value by Region (2019-2024)
5.1.3 Global Pet Drug Sales Value by Region (2025-2030)
5.1.4 Global Pet Drug Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pet Drug Sales Value, 2019-2030
5.2.2 North America Pet Drug Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pet Drug Sales Value, 2019-2030
5.3.2 Europe Pet Drug Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pet Drug Sales Value, 2019-2030
5.4.2 Asia Pacific Pet Drug Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pet Drug Sales Value, 2019-2030
5.5.2 South America Pet Drug Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pet Drug Sales Value, 2019-2030
5.6.2 Middle East & Africa Pet Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pet Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pet Drug Sales Value
6.3 United States
6.3.1 United States Pet Drug Sales Value, 2019-2030
6.3.2 United States Pet Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pet Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pet Drug Sales Value, 2019-2030
6.4.2 Europe Pet Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pet Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pet Drug Sales Value, 2019-2030
6.5.2 China Pet Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pet Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pet Drug Sales Value, 2019-2030
6.6.2 Japan Pet Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pet Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pet Drug Sales Value, 2019-2030
6.7.2 South Korea Pet Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pet Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pet Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Pet Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pet Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pet Drug Sales Value, 2019-2030
6.9.2 India Pet Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pet Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Profile
7.1.2 Zoetis Main Business
7.1.3 Zoetis Pet Drug Products, Services and Solutions
7.1.4 Zoetis Pet Drug Revenue (US$ Million) & (2019-2024)
7.1.5 Zoetis Recent Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Profile
7.2.2 Boehringer Ingelheim Main Business
7.2.3 Boehringer Ingelheim Pet Drug Products, Services and Solutions
7.2.4 Boehringer Ingelheim Pet Drug Revenue (US$ Million) & (2019-2024)
7.2.5 Boehringer Ingelheim Recent Developments
7.3 Merck Animal Health
7.3.1 Merck Animal Health Profile
7.3.2 Merck Animal Health Main Business
7.3.3 Merck Animal Health Pet Drug Products, Services and Solutions
7.3.4 Merck Animal Health Pet Drug Revenue (US$ Million) & (2019-2024)
7.3.5 Elanco Animal Health Recent Developments
7.4 Elanco Animal Health
7.4.1 Elanco Animal Health Profile
7.4.2 Elanco Animal Health Main Business
7.4.3 Elanco Animal Health Pet Drug Products, Services and Solutions
7.4.4 Elanco Animal Health Pet Drug Revenue (US$ Million) & (2019-2024)
7.4.5 Elanco Animal Health Recent Developments
7.5 Virbac
7.5.1 Virbac Profile
7.5.2 Virbac Main Business
7.5.3 Virbac Pet Drug Products, Services and Solutions
7.5.4 Virbac Pet Drug Revenue (US$ Million) & (2019-2024)
7.5.5 Virbac Recent Developments
7.6 Dechra Veterinary Products
7.6.1 Dechra Veterinary Products Profile
7.6.2 Dechra Veterinary Products Main Business
7.6.3 Dechra Veterinary Products Pet Drug Products, Services and Solutions
7.6.4 Dechra Veterinary Products Pet Drug Revenue (US$ Million) & (2019-2024)
7.6.5 Dechra Veterinary Products Recent Developments
7.7 Ceva
7.7.1 Ceva Profile
7.7.2 Ceva Main Business
7.7.3 Ceva Pet Drug Products, Services and Solutions
7.7.4 Ceva Pet Drug Revenue (US$ Million) & (2019-2024)
7.7.5 Ceva Recent Developments
7.8 Vetoquinol
7.8.1 Vetoquinol Profile
7.8.2 Vetoquinol Main Business
7.8.3 Vetoquinol Pet Drug Products, Services and Solutions
7.8.4 Vetoquinol Pet Drug Revenue (US$ Million) & (2019-2024)
7.8.5 Vetoquinol Recent Developments
7.9 Meiji
7.9.1 Meiji Profile
7.9.2 Meiji Main Business
7.9.3 Meiji Pet Drug Products, Services and Solutions
7.9.4 Meiji Pet Drug Revenue (US$ Million) & (2019-2024)
7.9.5 Meiji Recent Developments
7.10 Ouro Fino Saude
7.10.1 Ouro Fino Saude Profile
7.10.2 Ouro Fino Saude Main Business
7.10.3 Ouro Fino Saude Pet Drug Products, Services and Solutions
7.10.4 Ouro Fino Saude Pet Drug Revenue (US$ Million) & (2019-2024)
7.10.5 Ouro Fino Saude Recent Developments
7.11 Parnell
7.11.1 Parnell Profile
7.11.2 Parnell Main Business
7.11.3 Parnell Pet Drug Products, Services and Solutions
7.11.4 Parnell Pet Drug Revenue (US$ Million) & (2019-2024)
7.11.5 Parnell Recent Developments
8 Industry Chain Analysis
8.1 Pet Drug Industrial Chain
8.2 Pet Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pet Drug Sales Model
8.5.2 Sales Channel
8.5.3 Pet Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Pet Drug Market Trends
    Table 2. Pet Drug Market Drivers & Opportunity
    Table 3. Pet Drug Market Challenges
    Table 4. Pet Drug Market Restraints
    Table 5. Global Pet Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pet Drug Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Pet Drug Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Pet Drug Product Type
    Table 9. Key Companies Time to Begin Mass Production of Pet Drug
    Table 10. Global Pet Drug Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Drug as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Pet Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Pet Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Pet Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Pet Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Pet Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Pet Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Pet Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Pet Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Pet Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Pet Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Pet Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Pet Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Pet Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Pet Drug Sales Value by Region (2019-2024) & (%)
    Table 27. Global Pet Drug Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Pet Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Pet Drug Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Pet Drug Sales Value, (2025-2030) & (US$ Million)
    Table 31. Zoetis Basic Information List
    Table 32. Zoetis Description and Business Overview
    Table 33. Zoetis Pet Drug Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Pet Drug Business of Zoetis (2019-2024)
    Table 35. Zoetis Recent Developments
    Table 36. Boehringer Ingelheim Basic Information List
    Table 37. Boehringer Ingelheim Description and Business Overview
    Table 38. Boehringer Ingelheim Pet Drug Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Pet Drug Business of Boehringer Ingelheim (2019-2024)
    Table 40. Boehringer Ingelheim Recent Developments
    Table 41. Merck Animal Health Basic Information List
    Table 42. Merck Animal Health Description and Business Overview
    Table 43. Merck Animal Health Pet Drug Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Pet Drug Business of Merck Animal Health (2019-2024)
    Table 45. Merck Animal Health Recent Developments
    Table 46. Elanco Animal Health Basic Information List
    Table 47. Elanco Animal Health Description and Business Overview
    Table 48. Elanco Animal Health Pet Drug Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Pet Drug Business of Elanco Animal Health (2019-2024)
    Table 50. Elanco Animal Health Recent Developments
    Table 51. Virbac Basic Information List
    Table 52. Virbac Description and Business Overview
    Table 53. Virbac Pet Drug Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Pet Drug Business of Virbac (2019-2024)
    Table 55. Virbac Recent Developments
    Table 56. Dechra Veterinary Products Basic Information List
    Table 57. Dechra Veterinary Products Description and Business Overview
    Table 58. Dechra Veterinary Products Pet Drug Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Pet Drug Business of Dechra Veterinary Products (2019-2024)
    Table 60. Dechra Veterinary Products Recent Developments
    Table 61. Ceva Basic Information List
    Table 62. Ceva Description and Business Overview
    Table 63. Ceva Pet Drug Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Pet Drug Business of Ceva (2019-2024)
    Table 65. Ceva Recent Developments
    Table 66. Vetoquinol Basic Information List
    Table 67. Vetoquinol Description and Business Overview
    Table 68. Vetoquinol Pet Drug Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Pet Drug Business of Vetoquinol (2019-2024)
    Table 70. Vetoquinol Recent Developments
    Table 71. Meiji Basic Information List
    Table 72. Meiji Description and Business Overview
    Table 73. Meiji Pet Drug Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Pet Drug Business of Meiji (2019-2024)
    Table 75. Meiji Recent Developments
    Table 76. Ouro Fino Saude Basic Information List
    Table 77. Ouro Fino Saude Description and Business Overview
    Table 78. Ouro Fino Saude Pet Drug Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Pet Drug Business of Ouro Fino Saude (2019-2024)
    Table 80. Ouro Fino Saude Recent Developments
    Table 81. Parnell Basic Information List
    Table 82. Parnell Description and Business Overview
    Table 83. Parnell Pet Drug Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Pet Drug Business of Parnell (2019-2024)
    Table 85. Parnell Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Pet Drug Downstream Customers
    Table 89. Pet Drug Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Pet Drug Product Picture
    Figure 2. Global Pet Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pet Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Pet Drug Report Years Considered
    Figure 5. Global Pet Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pet Drug Revenue in 2023
    Figure 7. Pet Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Antiparasitic Drugs Picture
    Figure 9. Antibacterial Picture
    Figure 10. Other Picture
    Figure 11. Global Pet Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Pet Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Dogs
    Figure 14. Product Picture of Cats
    Figure 15. Product Picture of Other
    Figure 16. Global Pet Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Pet Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Pet Drug Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Pet Drug Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Pet Drug Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Pet Drug Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Pet Drug Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Pet Drug Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Pet Drug Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Pet Drug Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Pet Drug Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Pet Drug Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Pet Drug Sales Value (%), (2019-2030)
    Figure 29. United States Pet Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Pet Drug Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Pet Drug Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Pet Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Pet Drug Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Pet Drug Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Pet Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Pet Drug Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Pet Drug Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Pet Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Pet Drug Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Pet Drug Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Pet Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Pet Drug Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Pet Drug Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Pet Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Pet Drug Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Pet Drug Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Pet Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Pet Drug Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Pet Drug Sales Value by Application (%), 2023 VS 2030
    Figure 50. Pet Drug Industrial Chain
    Figure 51. Pet Drug Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS